Well, holding a lot of covered calls, I got screwed by the spike in IV and I'm currently trying to figure out what its from.
I see that lotus ends in 16 weeks from a point in 2013. That could be. It could be ascend endpoint moves up. It could be PANORAMA for the use of NAC. Any insights?
You left out another scenario. The stock runs to 2.30 and crede doesn't get the deal that they thought they were getting.
There's not actually going on. Only 7 contracts traded, the difference in the price is that it's been day/weeks since the last 17 contract was traded, and the stock has increased in price so the contract is worth less. There just isn't a lot of action in that particular contract.
Thanks chas, i went through the conference just now and am impressed by it. It looks like a good opportunity to buy tomorrow if it's in the red.
As far as I can tell, the information that Jagan is posting is incorrect. Short analytics reports that less than 15% of the shares sold yesterday are being sold short.
Wait, you didn't cover your short position with options? Silly short, that's basic investing 101.
Did anyone see that after hours trade, 65000 shares traded in one block for 14.65? I'd guess it's an institutional trade that was planned at daily average price or something and transferred in the after hours.
Lol what are you like mega short? This isn't disastrous news for ITMN, it's been known that others are attempting to make treatments for ipf for a while.
I've been with this stock since the fall from 50 to 7. I felt like the run up from 7 to 18 was a gift, and i unloaded about half of what i had then, because i felt a 20% correction was in order.
Here is my take on ITMN: the fall to 14.5 was warranted. After all, we are facing a decision that could be excellent or catastrophic in may and i could understand some people who got in at 7/8/9 wanting to get out while the price was around 16-18.
I think the selling from 14 and below is driven primarily on panic. The stock started to move up from 14 at the beginning of the day, so it's clear we have buyers above 14. I just don't think anyone knows exactly what is driving the sell off. It appears that it's the evidence of competition, but that competition is a year off and the market is supposedly large enough to support both.
I will remain a buyer of shares at 13.50-14 and a buyer of calls at less than 13.50. Since we may see the 12's, i'll prob time my call purchase for then.
wow 3.0% up to 250 million in sales in either us or europe, and it looks like we'll be under that for a while. US looks to have stagnated and even if europe came up to 100 million it would be a different territory so we wouldn't break out of the 3.0% tier. Well, buy calls on this stock was definitely a dumb idea. Ooops.
the overallotment was filled at the same price as the rest of the offering, 14.50, to my knowledge. All of those shares are tied up now and not on the market so it's not like there will be additional shares flooding the market. There's simply a lot of demand for KERX shares.
WOW epic high pricing. This shows that there's tremendous faith in KERX!!!
NEW YORK , Jan. 22, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc.(KERX) today announced the pricing of an underwritten public offering of common stock consisting of 6,900,000 shares at $14.50 per share.
I'm very positive about this dilution. The 6% is a dilution, and if the price on the shares is high it means that there was good support among the institutions that these were sold to at this 12-14 dollar level for kerx.
Regardless of what the CEO says, it's unrealistic to think that the company can market a drug alone without substantial money.
Furthermore, I'm not sure where you have a quote from him saying no more dilution, but if Ron said no dilution when the stock was 12 dollars and then it runs up to 16.00, I'd be quite happy with him making an opportune dilution. Did you see tesla's dilution at 90 dollars? It rallied off that because it gave them 700 million in the bank.